Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

462 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Innate and adaptive immune cells in the tumor microenvironment.
Gajewski TF, Schreiber H, Fu YX. Gajewski TF, et al. Nat Immunol. 2013 Oct;14(10):1014-22. doi: 10.1038/ni.2703. Nat Immunol. 2013. PMID: 24048123 Free PMC article. Review.
Immunotherapy with agonistic anti-CD137: two sides of a coin.
Sun Y, Chen JH, Fu Y. Sun Y, et al. Cell Mol Immunol. 2004 Feb;1(1):31-6. Cell Mol Immunol. 2004. PMID: 16212918 Review.
The critical role of LIGHT, a TNF family member, in T cell development.
Wang J, Chun T, Lo JC, Wu Q, Wang Y, Foster A, Roca K, Chen M, Tamada K, Chen L, Wang CR, Fu YX. Wang J, et al. J Immunol. 2001 Nov 1;167(9):5099-105. doi: 10.4049/jimmunol.167.9.5099. J Immunol. 2001. PMID: 11673520
Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine.
Meng Y, Efimova EV, Hamzeh KW, Darga TE, Mauceri HJ, Fu YX, Kron SJ, Weichselbaum RR. Meng Y, et al. Mol Ther. 2012 May;20(5):1046-55. doi: 10.1038/mt.2012.19. Epub 2012 Feb 14. Mol Ther. 2012. PMID: 22334019 Free PMC article.
Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculature.
Spaapen RM, Leung MY, Fuertes MB, Kline JP, Zhang L, Zheng Y, Fu YX, Luo X, Cohen KS, Gajewski TF. Spaapen RM, et al. J Immunol. 2014 Oct 15;193(8):4254-60. doi: 10.4049/jimmunol.1401109. Epub 2014 Sep 12. J Immunol. 2014. PMID: 25217157
462 results
Jump to page
Feedback